Dr. Jinyong Peng is currently working as the dean of the College of Pharmacy, Dalian Medical University. He received his PhD from The Second Military Medical University, Shanghai, China during the period of 2003-2006, and last received his post-doctoral degree in Analytical Chemistry from Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, China. As the corresponding author, he has published some papers in Theranostics, Redox Biology, Chemical Communications, Free Radical Biology and Medicine, Archives of Toxicology, British Journal of Pharmacology, and Pharmacological Research. His research interests include investigating the activities, drug targets on proteins or peptide, Toxicology and mechanisms of natural products or functional foods associated with oxidative stress against organ damage and metabolic disease. He is serving as an Associate Editor or Editorial Member of more than ten reputed journals including British Journal of Pharmacology

Srinivasa Reddy Bonam graduated from the Chalapathi Institute of Pharmaceutical Sciences in Guntur, India, with bachelor's and master's degrees in pharmacy. Under the supervision of Dr. H.M. Sampath Kumar, he received his PhD in 2018 from the AcSIR at the IICT in India, where he focused on the development of novel immunomodulators and vaccine adjuvants against infectious diseases. He received a Raman Charpak Fellowship to carry out research at the IBMC at the University of Strasbourg. From 2018 to early 2020, he worked as a postdoctoral researcher at IBMC, University of Strasbourg, France, under the supervision of Prof. Sylviane Muller. At IBMC, he worked on the P140 (Lupuzor®), a 21-mer peptide that combats systemic lupus erythematosus. Later, he joined with Prof. Jagadeesh Bayry at INSERM, CRC, Paris, France to work on the host-pathogen interaction and the 'next-generation flu vaccines for the world'. He is currently continuing his postdoctoral research on the development of mRNA vaccines for emerging infectious diseases at the University of Texas Medical Branch in Galveston, Texas, USA. He has a 20 h-index, 70 publications, and over 1,400 citations. He holds three patents, one of which was recently licensed to a private company. He serves on the editorial boards of several journals. He has been a member of several professional associations and currently serves on the Society of Leukocyte Biology's professional development committee.

Dr. Haiyun Xu graduated from Peking Union Medical College in 1996 with a doctorate in Medicine. He has vast experience of teaching medical students and supervising graduate students in the USA, Canada, and China. Currently, he is a full professor at the School of Psychiatry, Wenzhou Medical University, China. He has published over 90 academic articles that have been cited more than 3,300 times. His research fields include Biopsychiatry and Psychopharmacology. He has been serving for 16 journals as an associate editor or editorial board member.

Dr Daniel Ricardo Delgado is Biology and Chemistry graduate of Universidad Surcolombiana, Neiva, Colombia. He obtained his master's degree in Chemistry and his Ph.D in Pharmaceutical Sciences from the National University of Colombia, Bogotá, Colombia and now is professor and researcher at the Universidad Cooperativa de Colombia. Dr Delgado has published more than 100 papers in peer reviewed journals. Dr. Delgado’s primary research interests include drug solubility, cosolvency, pharmacology, and pharmacoeconomics.

Dr. George P.H. Leung obtained his BPharm and PhD degrees from the Chinese University of Hong Kong. He received his post-doctoral training from the Department of Medicine, Johns Hopkins University. He is currently an Associate Professor at the Department of Pharmacology and Pharmacy at the University of Hong Kong. He has published on 100 peer-review papers. His expertise is cardiovascular pharmacology, with special interest in nucleoside transporters and natural products.

Dr. Xu Youzhi is an Associated professor and Master Supervisor of Anhui Medical University. He earned PhD degree of Pharmacology in Sichuan University. Visiting Scholar of University of Tasmania (2015) and Morehouse School of Medicine (2018); Postdoctoral Research Fellow / Scholar of Memorial Sloan Kettering Cancer Center (MSKCC, 2019) and University of Kentucky (2019-2020); Membership of Pathophysiology Society of China; Membership of Committee of Tumor Biomarker of CACA; Associate Membership of AACR. He has published 30 papers in FASEB J., Cell Death Discov., British J Pharmacol., et al.

Dr. Xufeng Tao is a Doctor of School of Chemical Engineering, Dalian University of Technology. He got his master’s degree from Dalian Medical University in 2015 and a bachelor’s degree from Qinghai Nationalities University in 2012. He has worked as an assistant laboratory technician in Dalian Medical University from 2015 to 2018. His previous studies have been focused on the pharmacodynamics of natural products of Traditional Chinese Medicine. His current study is focused on the transformation mechanism from pancreatitis to pancreatic cancer. He has published several SCI papers as the first author or co-first author in recent years.

Dr. Chi-Ming Liu completed PhD from Kaohsiung Medical University in 2009. He is currently an associate professor in Yichun University, China. His research interests focus on evaluating and developing pharmacological actions of natural products and clinical drugs in prostate cancers and benign prostatic hyperplasia for clinical applications. He published 27 scientific papers and one book chapter.

Dante Marciani, President & Chief Scientific Officer of Qantu Therapeutics, Inc, holds a Sc.D. in Biology from the Universidad Nacional Mayor de San Marco, Lima – Peru, where he was an Assistant Professor, and a Ph.D. in Chemistry from the University of Colorado at Boulder, CO. He was a scientist at NIH, Bethesda, MD. His work led to the first commercial rec. DNA based HIV serological test, a veterinary subunit vaccine against FeLV, and the development of novel immune agonists, like QS-21, GPI-0100 and QT-0101. His current research focuses on anti-inflammatory vaccine adjuvants for autoimmune conditions and proteopathies.

Dr T.S. Mohamed Saleem completed his PhD (Faculty of Pharmacy) from JNTUK, Kakinada and M. Pharm, B. Pharm from Tamil Nadu Dr M G R Medical University, Chennai. Currently, he is an Assistant Professor in Pharmacology from the College of Pharmacy, Riyadh ELM University, Kingdom of Saudi Arabia. He has received a young investigator fellowship award from European Atherosclerosis Society, Sweden for his PhD research work. He has received an award in the year 2015, as a reviewer of the Elsevier European Journal of Integrative Medicine. He has published 80 research and review articles in national and international peer-reviewed journals and has also published 2 books.

Dr. Mehmet Öztürk is Professor of Analytical Chemistry at the Muğla Sıtkı Koçman University and the Assistant Manager of Food Analysis Application and Research Center at the same University. Dr. Öztürk received his Chemist degree from the Mediterranean University at 1998 and received his Ph.D. on Analytical Chemistry at Faculty of Pharmacy of Istanbul University at 2008. He is one of the leading research experts in the area of Natural Products Chemistry and Food Chemistry, as well as in vitro biological activities. He has published more 100 papers and 3 books chapter in the area of chemical ingredients of natural products related to Food and Pharmaceutical Chemistry. Recently, he has been working on cytotoxic and immunomodulatory activity of Mushrooms. Nowadays, Dr. Öztürk also focusses on various types of honey origins and to solve their adulteration. Dr. Öztürk serves on various project review committees including TUBITAK (The Scientific and Technological Research Council of Turkey) projects, and also gives lectures on the preparation of both international and national projects. His recent h-index is over 28 (webometrics) and 22 (publons).

Dr. Rongrui Wei received her Ph.D. from China Pharmaceutical University. Since 2017, she has been working at the Research Center of Natural Resources of Chinese Medicinal Materials and Ethnic Medicine, Jiangxi University of Traditional Chinese Medicine. Her area of interest is the pharmacology of Chinese material medical and ethnic medicine. She has published more than fifteen research papers in peer reviewed journals.

Dr. Guoqiang Chang received his Bachelor's degree from Tianjin Medical University with a major in pharmacy and received Ph.D. degree from Peking Union Medical College with majors in pathology and pathophysiology. Then, he worked as a postdoctoral fellow at Brown Foundation Institute for Molecular Medicine at The University of Texas and The University of Texas MD Anderson Cancer Center (2016-2018), as an instructor in Virginia Commonwealth University (2018-2021). He is now an associate professor in Tianjin Medical University General Hospital. His research focuses on the mechanism of tumorigenesis, signaling pathway in tumor, gene post-transcriptional modification and chemotherapy for tumor.

Dr. Tijana Bojić, MD PhD, Research Professor, was born on January 2nd 1974 in Belgrade, Yugoslavia. She received her PhD in Integrative Physiology at University of Bologna, Italy. Her research interests are integrative physiology and pathophysiology (states of vigilance and neurocardiovascular pathophysiology in specific), bioingeneering and bioinformatics in neuroscience. She published 36 in extenso scientific papers; one book chapter; one e-book; She is Associate Editor of Frontiers in Neuroscience/Neurology/Physiology, section Autonomic Neuroscience; Review Editor of Frontiers for Young Minds, Understanding Neuroscience; reviewer for 9 international scientific papers; mentor of one PhD thesis and the mentor of one state awarded High School scientific paper.

Dr. Binan Lu received her Bachelor's and Master’s degree from Dalian Medical University, Dalian, China, in 2007 and 2010. She received her Ph.D degree from Minzu University of China, Beijing, China in 2013. Dr Lu is an assistant Professor in the School of Pharmacy, Minzu University of China, Beijing, since 2013. Her research interests include ethnopharmacology on diabetes and liver injury.

Lei Li, female, is the Doctor of Pharmacy, Associate professor, Department of Pharmacy, Dalian Medical University. As a visiting scholar, she has been to Deakin University Medical School in Australia and the University of North Carolina at Chapel Hill in the United States. She has presided over one National Natural Science Foundation project, several provincial projects, and participated in 10 national scientific research projects. In the past five years, she has published more than 10 SCI papers as the first author and corresponding author.